BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 36980246)

  • 1. A Systematic Review of Progress toward Unlocking the Power of Epigenetics in NSCLC: Latest Updates and Perspectives.
    Sulewska A; Pilz L; Manegold C; Ramlau R; Charkiewicz R; Niklinski J
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
    Zhong S; Fields CR; Su N; Pan YX; Robertson KD
    Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research Progress of Epigenetic Mechanism in Acquired Resistance of 
Targeted Therapy in Non-small Cell Lung Cancer].
    Ai X; Wang Y
    Zhongguo Fei Ai Za Zhi; 2021 Oct; 24(10):705-713. PubMed ID: 34696542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics in non-small cell lung carcinomas.
    Peralta-Arrieta I; Armas-López L; Zúñiga J; Ávila-Moreno F
    Salud Publica Mex; 2019; 61(3):318-328. PubMed ID: 31276346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic therapy approaches in non-small cell lung cancer: Update and perspectives.
    Schiffmann I; Greve G; Jung M; Lübbert M
    Epigenetics; 2016 Dec; 11(12):858-870. PubMed ID: 27846368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
    Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
    Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
    [No Abstract]   [Full Text] [Related]  

  • 7. Independent Validation of Early-Stage Non-Small Cell Lung Cancer Prognostic Scores Incorporating Epigenetic and Transcriptional Biomarkers With Gene-Gene Interactions and Main Effects.
    Zhang R; Chen C; Dong X; Shen S; Lai L; He J; You D; Lin L; Zhu Y; Huang H; Chen J; Wei L; Chen X; Li Y; Guo Y; Duan W; Liu L; Su L; Shafer A; Fleischer T; Moksnes Bjaanæs M; Karlsson A; Planck M; Wang R; Staaf J; Helland Å; Esteller M; Wei Y; Chen F; Christiani DC
    Chest; 2020 Aug; 158(2):808-819. PubMed ID: 32113923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis.
    Duruisseaux M; Martínez-Cardús A; Calleja-Cervantes ME; Moran S; Castro de Moura M; Davalos V; Piñeyro D; Sanchez-Cespedes M; Girard N; Brevet M; Giroux-Leprieur E; Dumenil C; Pradotto M; Bironzo P; Capelletto E; Novello S; Cortot A; Copin MC; Karachaliou N; Gonzalez-Cao M; Peralta S; Montuenga LM; Gil-Bazo I; Baraibar I; Lozano MD; Varela M; Ruffinelli JC; Palmero R; Nadal E; Moran T; Perez L; Ramos I; Xiao Q; Fernandez AF; Fraga MF; Gut M; Gut I; Teixidó C; Vilariño N; Prat A; Reguart N; Benito A; Garrido P; Barragan I; Emile JF; Rosell R; Brambilla E; Esteller M
    Lancet Respir Med; 2018 Oct; 6(10):771-781. PubMed ID: 30100403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics of Sepsis.
    Binnie A; Tsang JLY; Hu P; Carrasqueiro G; Castelo-Branco P; Dos Santos CC
    Crit Care Med; 2020 May; 48(5):745-756. PubMed ID: 32167492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Suppression of the T-box Subfamily 2 (
    Nehme E; Rahal Z; Sinjab A; Khalil A; Chami H; Nemer G; Kadara H
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30866410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic predictive biomarkers for response or outcome to platinum-based chemotherapy in non-small cell lung cancer, current state-of-art.
    Szejniuk WM; Robles AI; McCulloch T; Falkmer UGI; Røe OD
    Pharmacogenomics J; 2019 Feb; 19(1):5-14. PubMed ID: 30190521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new insight on reciprocal relationship between microRNA expression and epigenetic modifications in human lung cancer.
    Sheervalilou R; Shirvaliloo S; Fekri Aval S; Khamaneh AM; Sharifi A; Ansarin K; Zarghami N
    Tumour Biol; 2017 May; 39(5):1010428317695032. PubMed ID: 28468581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance.
    Grasse S; Lienhard M; Frese S; Kerick M; Steinbach A; Grimm C; Hussong M; Rolff J; Becker M; Dreher F; Schirmer U; Boerno S; Ramisch A; Leschber G; Timmermann B; Grohé C; Lüders H; Vingron M; Fichtner I; Klein S; Odenthal M; Büttner R; Lehrach H; Sültmann H; Herwig R; Schweiger MR
    Genome Med; 2018 Jul; 10(1):55. PubMed ID: 30029672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Alterations and Inflammation as Emerging Use for the Advancement of Treatment in Non-Small Cell Lung Cancer.
    Yang S; Huang Y; Zhao Q
    Front Immunol; 2022; 13():878740. PubMed ID: 35514980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting DNA methyltransferases in non-small-cell lung cancer.
    Al-Yozbaki M; Jabre I; Syed NH; Wilson CM
    Semin Cancer Biol; 2022 Aug; 83():77-87. PubMed ID: 33486076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA as potential biomarkers in non-small-cell lung cancer: What do we know so far?
    Osielska MA; Jagodziński PP
    Biomed Pharmacother; 2018 May; 101():322-333. PubMed ID: 29499406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLC.
    Horie M; Kaczkowski B; Ohshima M; Matsuzaki H; Noguchi S; Mikami Y; Lizio M; Itoh M; Kawaji H; Lassmann T; Carninci P; Hayashizaki Y; Forrest ARR; Takai D; Yamaguchi Y; Micke P; Saito A; Nagase T
    Mol Cancer Res; 2017 Oct; 15(10):1354-1365. PubMed ID: 28698358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetics and cell cycle regulation in cystogenesis.
    Li X
    Cell Signal; 2020 Apr; 68():109509. PubMed ID: 31874209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics in lung cancer diagnosis and therapy.
    Mehta A; Dobersch S; Romero-Olmedo AJ; Barreto G
    Cancer Metastasis Rev; 2015 Jun; 34(2):229-41. PubMed ID: 25939322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SFRP1 is a possible candidate for epigenetic therapy in non-small cell lung cancer.
    Taguchi YH; Iwadate M; Umeyama H
    BMC Med Genomics; 2016 Aug; 9 Suppl 1(Suppl 1):28. PubMed ID: 27534621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.